Sanofi Clears Cancer Drug From More Generic Competition
A federal judge in Delaware has come down on the side of Sanofi in the major drugmaker's efforts to assert one of the newer patents it landed on a blockbuster drug...To view the full article, register now.
Already a subscriber? Click here to view full article